Skip to main content
Clinical Trials/NCT05941065
NCT05941065RecruitingNot Applicable

Open-label, Prospective Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin

Integrative Skin Science and Research2 sites in 1 country30 target enrollmentStarted: September 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
2
Primary Endpoint
C. acnes relative abundance

Study Overview

Brief Summary

The purpose of this study is to assess the safety of the skin balancing gel cream and examine the effects it has on the skin microbiome of individuals with non-cystic acne prone skin.

Detailed Description

Acne, a chronic inflammatory condition, is estimated to affect greater than 85% of the population at some point. It is considered a common skin condition characterized by pimples and occurs when follicles are clogged leading to the formation of acne lesions. In this study, we want to evaluate the impact the skin balancing gel cream has on the skin microbiome on individuals who have mild to moderate non-cystic acne. We will be assessing the changes it has on specific microbiota (Cutibacterium acnes for example) and whether it is tolerated well on acne prone skin.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Males and females between the ages of 18 years of age until 35 years of age
  • Males must be willing to shave facial hair
  • The presence of mild to moderate non-cystic acne based on investigator global assessment

Exclusion Criteria

  • Individuals who are pregnant or breastfeeding.
  • Prisoners.
  • Adults unable to consent.
  • The presence of severe acne or cysts as noted by the investigator.
  • Those who are unwilling to discontinue topical antibiotics, topical salicylic acid containing products and topical benzoyl peroxide containing products for two weeks to meet the washout criteria prior to enrolling.
  • Those who are unwilling to discontinue all facial topical products except the cleanser and the product provided in the study.
  • Individuals who have been on an oral antibiotic for acne within the previous 1 month.
  • Individuals who have changed any of their hormonal based contraception within
  • months prior to joining the study.
  • Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years.

Outcomes

Primary Outcomes

C. acnes relative abundance

Time Frame: 6 weeks

Shift in the C. acnes relative abundance based on skin microbiome swab collection and sequencing

Secondary Outcomes

  • Functional gene based predictive analysis of skin inflammation related genes(6 weeks)
  • Sebum excretion rate(6 weeks)
  • Tolerability Assessment Questionnaire(6 weeks)
  • Total lesion count(6 weeks)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials